Long before the COVID-19 pandemic shined a spotlight on CRISPR-based diagnostics, Kiana Aran, PhD, was developing the CRISPR-Chip. It was, according to Aran, the first transistor that uses CRISPR to ...

Predictive value for survival of a risk model of two serological markers, beta-2-microglobulin (B2M) and lactic dehydrogenase (LDH), in diffuse large cell lymphoma (DLCL) No significant financial ...

Hepatic arterial infusion (HAI) of oxaliplatin with either LV5FU2 or FOLFIRI in patients (pts) with refractory metastatic colorectal cancer (mCRC). This is an ASCO Meeting Abstract from the 2011 ASCO ...

Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic in late 2019, the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has undergone several mutations ...

Researchers from Tokyo Medical and Dental University (TMDU) and Cincinnati Children’s Hospital Medical Center (CCHMC) find that a point mutation in the glucokinase regulatory protein gene protects ...

In a recent study posted to the medRxiv* preprint server, researchers investigated the efficacy of diagnostic tests for identifying severe acute respiratory syndrome coronavirus (SARS-CoV-2) variants ...

SNP genotyping is an exciting field. The completion of the human genome sequencing project has enabled SNP research to move forward. SNP genotyping allows for further characterization of the human ...

A previously unidentified genetic mutation in a small protein provides significant protection against Parkinson's disease and offers a new direction for exploring potential treatments, according to a ...

Consumer DNA testing remains a booming industry, but new research released Monday suggests that it has a glaring flaw in its predictive power. The findings indicate that a common method of testing ...

Ryan Layer does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...